Cost-Effectiveness Analysis of CAR T-Cell Therapies vs Antibody Drug Conjugates for Patients with Advanced Multiple Myeloma.
Journal Information
Full Title: Cancer Control
Abbreviation: Cancer Control
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: AK has served as a member of scientific advisory boards for Abbvie, Alynylam, BMS, Cota Health, GSK, Janssen, Oncopeptide, Takeda. AK completed this work while a faculty member at UT Southwestern Medical Center; he is now an employee of Janssen. PR has served in Advisory Boards for Kite Pharma, Rafael Pharma and Pharmacyclics LLC. None of the other authors have any relevant conflicts of interest."
"Funding: The author(s) received no financial support for the research, authorship, and/or publication of this article."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025